Home › Metastatische kanker › Arizona › Scottsdale
Metastatische kanker klinische studies in Scottsdale, AZ
17 studies voor Metastatische kanker zoeken deelnemers op locaties in en rond Scottsdale (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
Rekruteren
- Mayo Clinic in Arizona, Scottsdale
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
RekruterenFase 2
- Mayo Clinic in Arizona, Scottsdale
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruterenFase 3
- Mayo Clinic, Scottsdale
- Ironwood Cancer & Research Centers, Scottsdale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruterenFase 3
- Ironwood Cancer & Research Centers, Scottsdale
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekruterenFase 1/2
- Mayo Clinic Arizona, Scottsdale
A Study of KK2269 in Adult Participants With Solid Tumors
RekruterenFase 1
- Mayo Clinic Arizona, Scottsdale
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
RekruterenFase 2
- Research Site, Scottsdale
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Honor Health, Scottsdale
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Mayo Clinic (Arizona), Scottsdale
A Study of PYX-201 in Advanced Solid Tumors
RekruterenFase 1
- HonorHealth Research Institute, Scottsdale
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Research Site, Scottsdale
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekruterenFase 2/3
- HonorHealth Research Insisute, Scottsdale
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruterenFase 1
- HonorHealth Research Institute, Scottsdale
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RekruterenFase 1
- Honor Health Research Institute, Scottsdale
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
RekruterenFase 1/2
- Honor Health Resarch Institute, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Scottsdale
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
RekruterenFase 1/2
- Mayo Clinic in Arizona, Scottsdale
Metastatische kanker studies in andere steden
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Andere studies in Scottsdale
- Borstkanker18 studies
- Kanker (alle vormen)18 studies
- Prostaatkanker17 studies
- Colorectale kanker16 studies
- Niet-kleincellige longkanker15 studies
- Aldermeesklierkanker13 studies
- Melanoom10 studies
- Colitis ulcerosa8 studies
- Longkanker8 studies
- Leverkanker (hepatocellulair carcinoom)7 studies
- Ziekte van Alzheimer7 studies
- Drievoudig negatieve borstkanker7 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.